{
  "trial_id": "NCT01885208",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, body mass index (BMI), duration of diabetes, baseline HbA1c, fasting plasma glucose, use of oral antidiabetic drugs (OADs), estimated glomerular filtration rate (eGFR), blood pressure, lipid profile, history of cardiovascular disease, smoking status, physical activity level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "baseline HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "fasting plasma glucose"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body Weight",
        "Systolic blood pressure",
        "Diastolic blood pressure",
        "Patient-reported outcome: Diabetes Treatment Satisfaction Questionnaire (DTSQ)"
      ],
      "remaining_candidate_features": [
        "race",
        "body mass index (BMI)",
        "duration of diabetes",
        "use of oral antidiabetic drugs (OADs)",
        "estimated glomerular filtration rate (eGFR)",
        "blood pressure",
        "lipid profile",
        "history of cardiovascular disease",
        "smoking status",
        "physical activity level"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, eGFR, Use of Oral Antidiabetic Drugs,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "Baseline HbA1c"
        ],
        [
          "Systolic blood pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic blood pressure",
          "Diastolic Blood Pressure"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Fasting Plasma Glucose",
        "Patient-reported outcome: Diabetes Treatment Satisfaction Questionnaire (DTSQ)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Duration of Diabetes",
        "Body Mass Index",
        "eGFR",
        "Use of Oral Antidiabetic Drugs"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Diabetes Diagnosis Duration, HbA1c, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Fasting Plasma Glucose, Total Cholesterol, Triglycerides, HDL Cholesterol, LDL Cholesterol, eGFR, History of Cardiovascular Disease.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Systolic blood pressure",
          "Systolic Blood Pressure"
        ],
        [
          "Diastolic blood pressure",
          "Diastolic Blood Pressure"
        ],
        [
          "Fasting Plasma Glucose",
          "Fasting Plasma Glucose"
        ]
      ],
      "remaining_reference_features": [
        "Body Weight",
        "Patient-reported outcome: Diabetes Treatment Satisfaction Questionnaire (DTSQ)"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Diabetes Diagnosis Duration",
        "Body Mass Index",
        "Total Cholesterol",
        "Triglycerides",
        "HDL Cholesterol",
        "LDL Cholesterol",
        "eGFR",
        "History of Cardiovascular Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, HbA1c, fasting plasma glucose, systolic blood pressure, diastolic blood pressure, heart rate, medical history, smoking status, use of concomitant medications, estimated glomerular filtration rate (eGFR), calcitonin value.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Glycosylated haemoglobin (HbA1c)",
          "HbA1c"
        ],
        [
          "Fasting Plasma Glucose",
          "fasting plasma glucose"
        ],
        [
          "Systolic blood pressure",
          "systolic blood pressure"
        ],
        [
          "Diastolic blood pressure",
          "diastolic blood pressure"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Body Weight",
        "Patient-reported outcome: Diabetes Treatment Satisfaction Questionnaire (DTSQ)"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "body mass index (BMI)",
        "duration of diabetes",
        "heart rate",
        "medical history",
        "smoking status",
        "use of concomitant medications",
        "estimated glomerular filtration rate (eGFR)",
        "calcitonin value."
      ]
    }
  }
}